EXCERPT: “Patients across Minnesota will soon have better access to new cancer treatments through clinical trials thanks to a new state-funded partnership between the University of Minnesota and the state’s major health systems. As part of Minnesota’s Discovery, Research and InnoVation Economy (MnDRIVE) partnership with the State of Minnesota, the University has launched the Minnesota Cancer Clinical Trials Network (MNCCTN) with multiple locations across the state. Led by the Masonic Cancer Center, University of Minnesota, the goal of the MNCCTN is to improve prevention, treatment and survivorship for all Minnesotans through greater access to cancer clinical trials. These trials will originate from Minnesota’s two NCI-Designated Comprehensive Cancer Centers, the Masonic Cancer Center and Mayo Clinic Cancer Center, along with the Hormel Institute in Austin.” FULLSTORY: http://bit.ly/2IGvoy6
